---
title: "GeoVax Labs | 8-K: FY2026 Q1 Revenue: USD 0"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286465060.md"
datetime: "2026-05-14T20:37:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286465060.md)
  - [en](https://longbridge.com/en/news/286465060.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286465060.md)
---

# GeoVax Labs | 8-K: FY2026 Q1 Revenue: USD 0

Revenue: As of FY2026 Q1, the actual value is USD 0.

EPS: As of FY2026 Q1, the actual value is USD -2.62, missing the estimate of USD -0.845.

EBIT: As of FY2026 Q1, the actual value is USD -5.284 M, missing the estimate of USD -5.019 M.

The provided reference explicitly states that it does not contain detailed financial or operational metrics, segment revenue, net income, gross margin, operating profit, cash flow, or any forward-looking statements or guidance for GeoVax Labs, Inc. for the quarter ended March 31, 2026.

### Related Stocks

- [GOVX.US](https://longbridge.com/en/quote/GOVX.US.md)

## Related News & Research

- [The Home Depot Announces First Quarter Fiscal 2026 Results; Reaffirms Fiscal 2026 Guidance | HD Stock News](https://longbridge.com/en/news/286890512.md)
- [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md)
- [FRONTERA ANNOUNCES FIRST QUARTER 2026 RESULTS | FECCF Stock News](https://longbridge.com/en/news/286507909.md)
- [Guardian Capital Announces May 2026 Cash Distributions for Guardian Capital ETFs](https://longbridge.com/en/news/286857337.md)
- [OS Therapies to Announce First Quarter 2026 Financials on Monday, May 18, 2026 | OSTX Stock News](https://longbridge.com/en/news/286607728.md)